---
title: "Mentari Therapeutics' Total Liabilities Rise to $78.61 Million From $10.26 Million at Year-End"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305668280.md"
description: "Mentari Therapeutics reported a significant increase in total liabilities to $78.61 million as of September 30, 2026, up from $10.26 million at year-end 2025. Noncurrent related-party liabilities reached $52.2 million, primarily due to convertible notes and accrued interest. Current liabilities rose to $26.41 million. Meanwhile, total assets grew to $52.44 million, while cash and cash equivalents slightly decreased to $45.79 million."
datetime: "2026-11-16T12:12:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305668280.md)
  - [en](https://longbridge.com/en/news/305668280.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305668280.md)
generator: "portal-rs"
---

# Mentari Therapeutics' Total Liabilities Rise to $78.61 Million From $10.26 Million at Year-End

-   Mentari Therapeutics’ total liabilities rose to $78.61 million at September 30, 2026, from $10.26 million at December 31, 2025. \* Noncurrent related-party liabilities reached $52.2 million, comprising a convertible note payable and accrued interest. \* Current liabilities increased to $26.41 million from $10.26 million. \* Total assets grew to $52.44 million from $46.3 million. \* Cash and cash equivalents edged down to $45.79 million from $46.26 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mentari Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-462017), on November 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [MTRI.US](https://longbridge.com/en/quote/MTRI.US.md)

## Related News & Research

- [MTRI: PACAP/CGRP pipeline targets more effective, less frequent migraine prevention](https://longbridge.com/en/news/305818527.md)
- [Wedbush initiates coverage of Mentari Therapeutics at Outperform, sets price target at $33](https://longbridge.com/en/news/305469432.md)
- [ADAR1 Capital Management reports acquisition of $34,571.592 in Mentari Therapeutics common shares](https://longbridge.com/en/news/304932745.md)
- [Mentari Therapeutics Publishes Pro Forma Combined Financial Statements With InMed Pharmaceuticals](https://longbridge.com/en/news/305072970.md)
- [Jefferies initiates coverage of Mentari Therapeutics at Buy, sets price target at $30](https://longbridge.com/en/news/305028486.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**